Prescription of Kampo drugs in the Japanese health care insurance program

Kotoe Katayama, Tetsuhiro Yoshino, Kaori Munakata, Rui Yamaguchi, Seiya Imoto, Satoru Miyano, Kenji Watanabe

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Kampo medicine or traditional Japanese medicine has been used under Japan's National Health Insurance scheme for 46 years. Recent research has shown that more than 80% of physicians use Kampo in daily practice. However, the use of Kampo from the patient perspective has received scant attention. To assess the current use of Kampo drugs in the National Health Insurance Program, we analysed a total of 67,113,579 health care claim records, which had been collected by Japan's Ministry of Health, Labour and Welfare in 2009. We found that Kampo drugs were prescribed for 1.34% of all patients. Among these, 92.2% simultaneously received biomedical drugs. Shakuyakukanzoto was the most frequently prescribed Kampo drug. The usage of frequently prescribed Kampo drugs differed between the youth and the elderly, males and females, and inpatients and outpatients. Kampo medicine has been employed in a wide variety of conditions, but the prescription rate was highest for disorders associated with pregnancy, childbirth, and the puerperium (4.08%). Although the adoption of Kampo medicine by physicians is large in a variety of diseases, the prescription rate of Kampo drugs is very limited.

Original languageEnglish
Article number576973
JournalEvidence-based Complementary and Alternative Medicine
Volume2013
DOIs
Publication statusPublished - 2013

Fingerprint

Kampo Medicine
Prescription Drugs
Health Insurance
Delivery of Health Care
National Health Programs
Pharmaceutical Preparations
Prescriptions
Japan
Physicians
Traditional Medicine
Postpartum Period
Inpatients
Outpatients

ASJC Scopus subject areas

  • Complementary and alternative medicine

Cite this

Katayama, K., Yoshino, T., Munakata, K., Yamaguchi, R., Imoto, S., Miyano, S., & Watanabe, K. (2013). Prescription of Kampo drugs in the Japanese health care insurance program. Evidence-based Complementary and Alternative Medicine, 2013, [576973]. https://doi.org/10.1155/2013/576973

Prescription of Kampo drugs in the Japanese health care insurance program. / Katayama, Kotoe; Yoshino, Tetsuhiro; Munakata, Kaori; Yamaguchi, Rui; Imoto, Seiya; Miyano, Satoru; Watanabe, Kenji.

In: Evidence-based Complementary and Alternative Medicine, Vol. 2013, 576973, 2013.

Research output: Contribution to journalArticle

Katayama, K, Yoshino, T, Munakata, K, Yamaguchi, R, Imoto, S, Miyano, S & Watanabe, K 2013, 'Prescription of Kampo drugs in the Japanese health care insurance program', Evidence-based Complementary and Alternative Medicine, vol. 2013, 576973. https://doi.org/10.1155/2013/576973
Katayama, Kotoe ; Yoshino, Tetsuhiro ; Munakata, Kaori ; Yamaguchi, Rui ; Imoto, Seiya ; Miyano, Satoru ; Watanabe, Kenji. / Prescription of Kampo drugs in the Japanese health care insurance program. In: Evidence-based Complementary and Alternative Medicine. 2013 ; Vol. 2013.
@article{5e457530abe54e5db80e7fb1377287d1,
title = "Prescription of Kampo drugs in the Japanese health care insurance program",
abstract = "Kampo medicine or traditional Japanese medicine has been used under Japan's National Health Insurance scheme for 46 years. Recent research has shown that more than 80{\%} of physicians use Kampo in daily practice. However, the use of Kampo from the patient perspective has received scant attention. To assess the current use of Kampo drugs in the National Health Insurance Program, we analysed a total of 67,113,579 health care claim records, which had been collected by Japan's Ministry of Health, Labour and Welfare in 2009. We found that Kampo drugs were prescribed for 1.34{\%} of all patients. Among these, 92.2{\%} simultaneously received biomedical drugs. Shakuyakukanzoto was the most frequently prescribed Kampo drug. The usage of frequently prescribed Kampo drugs differed between the youth and the elderly, males and females, and inpatients and outpatients. Kampo medicine has been employed in a wide variety of conditions, but the prescription rate was highest for disorders associated with pregnancy, childbirth, and the puerperium (4.08{\%}). Although the adoption of Kampo medicine by physicians is large in a variety of diseases, the prescription rate of Kampo drugs is very limited.",
author = "Kotoe Katayama and Tetsuhiro Yoshino and Kaori Munakata and Rui Yamaguchi and Seiya Imoto and Satoru Miyano and Kenji Watanabe",
year = "2013",
doi = "10.1155/2013/576973",
language = "English",
volume = "2013",
journal = "Evidence-based Complementary and Alternative Medicine",
issn = "1741-427X",
publisher = "Hindawi Publishing Corporation",

}

TY - JOUR

T1 - Prescription of Kampo drugs in the Japanese health care insurance program

AU - Katayama, Kotoe

AU - Yoshino, Tetsuhiro

AU - Munakata, Kaori

AU - Yamaguchi, Rui

AU - Imoto, Seiya

AU - Miyano, Satoru

AU - Watanabe, Kenji

PY - 2013

Y1 - 2013

N2 - Kampo medicine or traditional Japanese medicine has been used under Japan's National Health Insurance scheme for 46 years. Recent research has shown that more than 80% of physicians use Kampo in daily practice. However, the use of Kampo from the patient perspective has received scant attention. To assess the current use of Kampo drugs in the National Health Insurance Program, we analysed a total of 67,113,579 health care claim records, which had been collected by Japan's Ministry of Health, Labour and Welfare in 2009. We found that Kampo drugs were prescribed for 1.34% of all patients. Among these, 92.2% simultaneously received biomedical drugs. Shakuyakukanzoto was the most frequently prescribed Kampo drug. The usage of frequently prescribed Kampo drugs differed between the youth and the elderly, males and females, and inpatients and outpatients. Kampo medicine has been employed in a wide variety of conditions, but the prescription rate was highest for disorders associated with pregnancy, childbirth, and the puerperium (4.08%). Although the adoption of Kampo medicine by physicians is large in a variety of diseases, the prescription rate of Kampo drugs is very limited.

AB - Kampo medicine or traditional Japanese medicine has been used under Japan's National Health Insurance scheme for 46 years. Recent research has shown that more than 80% of physicians use Kampo in daily practice. However, the use of Kampo from the patient perspective has received scant attention. To assess the current use of Kampo drugs in the National Health Insurance Program, we analysed a total of 67,113,579 health care claim records, which had been collected by Japan's Ministry of Health, Labour and Welfare in 2009. We found that Kampo drugs were prescribed for 1.34% of all patients. Among these, 92.2% simultaneously received biomedical drugs. Shakuyakukanzoto was the most frequently prescribed Kampo drug. The usage of frequently prescribed Kampo drugs differed between the youth and the elderly, males and females, and inpatients and outpatients. Kampo medicine has been employed in a wide variety of conditions, but the prescription rate was highest for disorders associated with pregnancy, childbirth, and the puerperium (4.08%). Although the adoption of Kampo medicine by physicians is large in a variety of diseases, the prescription rate of Kampo drugs is very limited.

UR - http://www.scopus.com/inward/record.url?scp=84893774412&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84893774412&partnerID=8YFLogxK

U2 - 10.1155/2013/576973

DO - 10.1155/2013/576973

M3 - Article

AN - SCOPUS:84893774412

VL - 2013

JO - Evidence-based Complementary and Alternative Medicine

JF - Evidence-based Complementary and Alternative Medicine

SN - 1741-427X

M1 - 576973

ER -